Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 3108-3118, June 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hwang, Y. C.
Right arrow Articles by Ackerman, J. J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hwang, Y. C.
Right arrow Articles by Ackerman, J. J. H.

Modulation of Murine Radiation-induced Fibrosarcoma-1 Tumor Metabolism and Blood Flow in Situ via Glucose and Mannitol Administration Monitored by 31P and 2H Nuclear Magnetic Resonance Spectroscopy1

Yuying C. Hwang2, Seong-Gi Kim3, Jeffrey L. Evelhoch, Mahmoud Seyedsadr and Joseph J. H. Ackerman4

Department of Chemistry, Washington University, St. Louis, Missouri 63130 [Y. C. H., S-G. K., J. J. H. A.], and Division of Hematology and Oncology, Department of Internal Medicine [J. L. E.] and Department of Radiation Oncology [M. S.], Wayne State University School of Medicine, Detroit, Michigan 48201

The hyperglycemia-induced in situ metabolism and blood flow changes produced in s.c. implanted murine radiation-induced fibrosarcoma-1 tumors, grown on the flanks of female C3H/HeJ mice, were examined with 31P and 2H nuclear magnetic resonance. Initial experiments verified a hyperglycemic tumor acidification similar to that reported earlier with a different substrain of mice, C3H/AnF (J. L. Evelhoch et al., Proc. Natl. Acad. Sci. USA, 81: 6496–6500, 1984). Changes in the tumor pH, phosphorus metabolites, and blood flow were then compared after administration of saline, glucose, or mannitol (a nonmetabolizable glucose analogue) using a mole-equivalent dose of the sugars (i.e., 0.8 mmol/20g mouse). Neither saline (n = 8) nor mannitol (n = 6) administration had any marked effect upon tumor pH, whereas glucose administration produced a mean maximum tumor pH reduction of 0.74 ± 0.09 (SE; n = 9) during the 2.5 h post-glucose injection. No significant changes in high energy phosphate concentrations were observed during the same period after saline injection. After glucose injection, the [phosphocreatine] gradually decreased by 64% (P = 0.0001). After the initial 1 h post-glucose injection, the [inorganic phosphate] increased by 58% (P = 0.0001), and the [nucleoside triphosphates] decreased by 29% (P = 0.0001) during the following 1.5 h. After mannitol injection, while there was no change in [inorganic phosphate] over time (P = 0.37), the [phosphocreatine] decreased by 33% (P = 0.0001) and the [nucleoside triphosphates] decreased by 21% (P = 0.0015) within 20 min, then both the [phosphocreatine] and [nucleoside triphosphates] remained at constant levels during the following 2 h. In parallel experiments, the volumetric rate of tumor blood flow and perfusion was measured by 2H nuclear magnetic resonance monitoring of 2H2O washout kinetics (S-G. Kim and J. J. H. Ackerman, Cancer Res., 48: 3449–3453, 1988); tumor blood flow decreased by 80% (P = 0.0001, n = 11), 60% (P = 0.0031, n = 4), and 20% (P = 0.058, n = 10) at 2 h after glucose, mannitol, or saline injections, respectively. These results suggest that anaerobic glycolysis is a requirement for hyperglycemic tumor acidification. However, the decrease in tumor blood flow accompanying hyperglycemic acidification suggests that flow reduction also may be a contributing or a required cofactor for acidification via inhibition of lactic acid egress. These blood flow reductions are consistent with an observed increase in systemic hematocrit, by 8% (40–48%) or 10% (41–51%) during 2 h post-glucose or mannitol injection, which is expected to cause an increase in systemic as well as local tumor blood viscosity.

1 Support for this work was provided by NIH Grants CA-40411 and GM-30331, and National Science Foundation Instrument Grant CHE-8100211.

2 Present address: Kettering-Scott Magnetic Resonance Laboratory, Kettering Medical Center and Department of Biochemistry, Wright State University School of Medicine, 3535 Southern Boulevard, Kettering, OH 45429.

3 Present address: Department of Chemistry, University of Washington, Seattle, WA 98195.

4 To whom requests for reprints should be addressed, at Department of Chemistry, Campus Box 1134, Washington University, One Brookings Drive, St. Louis, MO 63130.

Received 6/ 6/89. Accepted 4/ 1/91.




This article has been cited by other articles:


Home page
Cancer Res.Home page
R. Zhou, N. Bansal, D. B. Leeper, and J. D. Glickson
Intracellular Acidification of Human Melanoma Xenografts by the Respiratory Inhibitor m-Iodobenzylguanidine Plus Hyperglycemia: A 31P Magnetic Resonance Spectroscopy Study
Cancer Res., July 1, 2000; 60(13): 3532 - 3536.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.